IRIS Accounts Production v24.3.0.553 07603091 director 1.5.23 30.4.24 30.4.24 false true false false false true false Ordinary A 1.00000 Ordinary B 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh076030912023-04-30076030912024-04-30076030912023-05-012024-04-30076030912022-04-30076030912022-05-012023-04-30076030912023-04-3007603091ns15:EnglandWales2023-05-012024-04-3007603091ns14:PoundSterling2023-05-012024-04-3007603091ns10:Director12023-05-012024-04-3007603091ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3007603091ns10:SmallEntities2023-05-012024-04-3007603091ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3007603091ns10:SmallCompaniesRegimeForDirectorsReport2023-05-012024-04-3007603091ns10:SmallCompaniesRegimeForAccounts2023-05-012024-04-3007603091ns10:FullAccounts2023-05-012024-04-300760309112023-05-012024-04-3007603091ns10:OrdinaryShareClass12023-05-012024-04-3007603091ns10:OrdinaryShareClass22023-05-012024-04-3007603091ns5:CurrentFinancialInstruments2024-04-3007603091ns5:CurrentFinancialInstruments2023-04-3007603091ns5:ShareCapital2024-04-3007603091ns5:ShareCapital2023-04-3007603091ns5:RetainedEarningsAccumulatedLosses2024-04-3007603091ns5:RetainedEarningsAccumulatedLosses2023-04-3007603091ns10:RegisteredOffice2023-05-012024-04-3007603091ns5:NetGoodwill2023-05-012024-04-3007603091ns5:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3007603091ns5:ComputerSoftware2023-05-012024-04-3007603091ns5:NetGoodwill2023-04-3007603091ns5:ComputerSoftware2023-04-3007603091ns5:NetGoodwill2024-04-3007603091ns5:ComputerSoftware2024-04-3007603091ns5:NetGoodwill2023-04-3007603091ns5:ComputerSoftware2023-04-3007603091ns5:FurnitureFittings2023-04-3007603091ns5:MotorVehicles2023-04-3007603091ns5:FurnitureFittings2023-05-012024-04-3007603091ns5:MotorVehicles2023-05-012024-04-3007603091ns5:FurnitureFittings2024-04-3007603091ns5:MotorVehicles2024-04-3007603091ns5:FurnitureFittings2023-04-3007603091ns5:MotorVehicles2023-04-3007603091ns5:UnlistedNon-exchangeTradedns5:CostValuation2023-04-3007603091ns5:UnlistedNon-exchangeTradedns5:DisposalsRepaymentsInvestments2024-04-3007603091ns5:UnlistedNon-exchangeTradedns5:CostValuation2024-04-3007603091ns5:UnlistedNon-exchangeTraded2024-04-3007603091ns5:UnlistedNon-exchangeTraded2023-04-3007603091ns5:WithinOneYearns5:CurrentFinancialInstruments2024-04-3007603091ns5:WithinOneYearns5:CurrentFinancialInstruments2023-04-3007603091ns10:OrdinaryShareClass12024-04-3007603091ns10:OrdinaryShareClass22024-04-30076030911ns10:Director12023-04-30076030911ns10:Director12022-04-30076030911ns10:Director12023-05-012024-04-30076030911ns10:Director12022-05-012023-04-30076030911ns10:Director12024-04-30076030911ns10:Director12023-04-30
REGISTERED NUMBER: 07603091 (England and Wales)















Unaudited Financial Statements for the Year Ended 30th April 2024

for

London Orthopaedic Partnership Ltd

London Orthopaedic Partnership Ltd (Registered number: 07603091)






Contents of the Financial Statements
for the Year Ended 30th April 2024




Page

Balance Sheet 1

Notes to the Financial Statements 3


London Orthopaedic Partnership Ltd (Registered number: 07603091)

Balance Sheet
30th April 2024

30.4.24 30.4.23
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 111,779 114,281
Tangible assets 5 12,617 15,844
Investments 6 21,060 11,152
145,456 141,277

CURRENT ASSETS
Debtors 7 17,315 24,483
Cash at bank 77,875 69,494
95,190 93,977
CREDITORS
Amounts falling due within one year 8 43,527 38,047
NET CURRENT ASSETS 51,663 55,930
TOTAL ASSETS LESS CURRENT
LIABILITIES

197,119

197,207

PROVISIONS FOR LIABILITIES 1,185 753
NET ASSETS 195,934 196,454

CAPITAL AND RESERVES
Called up share capital 9 101 101
Retained earnings 195,833 196,353
SHAREHOLDERS' FUNDS 195,934 196,454

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

London Orthopaedic Partnership Ltd (Registered number: 07603091)

Balance Sheet - continued
30th April 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 5th February 2025 and were signed by:





Dr M J Sala - Director


London Orthopaedic Partnership Ltd (Registered number: 07603091)

Notes to the Financial Statements
for the Year Ended 30th April 2024

1. COMPANY INFORMATION

London Orthopaedic Partnership Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 07603091

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Goodwill
Franchise costs, being the amount paid in connection with the acquisition of a business in 2011, is being amortised evenly over its estimated useful life of twenty years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Computer software is being amortised evenly over its estimated useful life of nil years.

Tangible fixed assets
Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures and Fittings - 25% on cost
Motor Vehicles - 18% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


London Orthopaedic Partnership Ltd (Registered number: 07603091)

Notes to the Financial Statements - continued
for the Year Ended 30th April 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Franchise Computer
costs software Totals
£    £    £   
COST
At 1st May 2023 368,635 - 368,635
Additions - 19,912 19,912
At 30th April 2024 368,635 19,912 388,547
AMORTISATION
At 1st May 2023 254,354 - 254,354
Amortisation for year 18,432 3,982 22,414
At 30th April 2024 272,786 3,982 276,768
NET BOOK VALUE
At 30th April 2024 95,849 15,930 111,779
At 30th April 2023 114,281 - 114,281

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor
fittings vehicles Totals
£    £    £   
COST
At 1st May 2023
and 30th April 2024 13,546 33,400 46,946
DEPRECIATION
At 1st May 2023 10,085 21,017 31,102
Charge for year 998 2,229 3,227
At 30th April 2024 11,083 23,246 34,329
NET BOOK VALUE
At 30th April 2024 2,463 10,154 12,617
At 30th April 2023 3,461 12,383 15,844

London Orthopaedic Partnership Ltd (Registered number: 07603091)

Notes to the Financial Statements - continued
for the Year Ended 30th April 2024

6. FIXED ASSET INVESTMENTS
Unlisted
investments
£   
COST OR VALUATION
At 1st May 2023 11,152
Disposals 9,908
At 30th April 2024 21,060
NET BOOK VALUE
At 30th April 2024 21,060
At 30th April 2023 11,152

Cost or valuation at 30th April 2024 is represented by:

Unlisted
investments
£   
Valuation in 2024 21,060

If had not been revalued would have been included at the following historical cost:

30.4.24 30.4.23
£    £   
Cost 21,060 21,060

Fixed asset investment represents holdings in Chiswick Outpatient Centre LLP and Regen Orthosport LLP. As there is no ascertainable market value available, the directors have valued these on a cost basis.

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Trade debtors 14,663 13,672
S455 recoverable 2,652 2,652
Directors' current accounts - 8,159
17,315 24,483

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.24 30.4.23
£    £   
Bank loans and overdrafts 605 1,954
Corporation tax payable 14,398 5,527
Social security and other taxes (3,146 ) -
Other creditors - LLP 4,893 2,492
Directors' current accounts 5,722 -
Accrued expenses 21,055 28,074
43,527 38,047

London Orthopaedic Partnership Ltd (Registered number: 07603091)

Notes to the Financial Statements - continued
for the Year Ended 30th April 2024

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.4.24 30.4.23
value: £    £   
100 Ordinary A £1 101 101
1 Ordinary B 1 - -
101 101

During the year 40 A shares and 1 B share was issued at par.

Ordinary A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

Ordinary B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B shares rank pari passu in terms of dividend and capital distribution rights

10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30th April 2024 and 30th April 2023:

30.4.24 30.4.23
£    £   
Dr M J Sala
Balance outstanding at start of year 8,159 38,866
Amounts advanced 50,000 22,000
Amounts repaid (63,881 ) (52,707 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (5,722 ) 8,159

The loan is repayable on demand and no interest was charged during the year.

11. CONTROL

The ultimate controlling party is Dr M Sala by virtue of holding 100% of the voting share capital.